浅谈公共卫生与疾病预防控制体系建设
Summary and Recommendations of Development of Public Health and Disease Prevention and Control
Summary and Recommendations of Development of Public Health and Disease Prevention and Control
作者
孙点剑一(北京大学 公共卫生学院 北京 100191)
李立明(北京大学 公共卫生学院 北京 100191)
李立明(北京大学 公共卫生学院 北京 100191)
中文关键词
新冠肺炎;公共卫生;疾病预防控制;体系
英文关键词
COVID-19;public health;disease control and prevention;system
中文摘要
此次新冠肺炎疫情传播速度快、影响范围广、防控难度大，在没有特异性治疗药物和疫苗的情况下，我国通过最全面彻底的、以“非医疗干预”手段为主的防控举措，全社会动员，全民参与，科学防治、精准防治，有效遏制了本土疫情，取得了阶段性重要成效。在此次疫情防控中，我国各级公共卫生与疾病预防控制（以下简称“疾控”）体系起到了重要作用，但也暴露出了诸多短板和不足。文章梳理了现阶段我国疾控体系、公共卫生法律法规建设、卫生应急管理政策保障3个方面存在的突出问题，提出了新时代疾控体系的职能任务发展、关键科研技术建设和专业人才资源储备3个方面的具体建议。
英文摘要
The COVID-19 epidemic in 2020 is an emergency public health event rapidly spreading and hard to prevent and control, causing catastrophic loss of life and almost paralyzing the society. In the absence of specific antiviral drugs and vaccines, China has effectively curbed the spread of COVID-19 by taking non-medical intervention actions decisively and precisely, with the multidepartmental collaborations and involvement of all communities and individuals. However, in the process of combating the epidemic, problems and shortcomings have also been clearly shown in the disease control system and the emergency response system. This review tried to address the weaknesses and issues presented in the COVID-19 epidemic regarding the current system of disease prevention and control, laws and regulations related to public health, and public health emergency management. Also, detailed recommendations were made, including the reform of the CDC system, the development of science and technology, as well as the boost of public health professionals training.
DOI10.16418/j.issn.1000-3045.20200717003
作者简介
孙点剑一 北京大学公共卫生学院流行病与卫生统计学系副研究员、博士生导师。作为骨干成员参与中国双生子登记系统(CNTR项目)和中国慢性病前瞻性研究(CKB项目),主要研究方向为慢性病流行病学、多组学分析、衰老及生命历程研究。
E-mail:dsun1@bjmu.edu.cn
SUN Dianjianyi Assistant Professor in the Department of Epidemiology&Biostatistics,School of Public Health,Peking University Health Science Center.His interest in epidemiology of cardiometabolic diseases led him to pursue a Ph.D.degree in Epidemiology and Biostatistics at Peking University.He completed his Ph.D.research investigating the role of DNA methylation in the development of cardiometabolic disorders from 2010 to 2015.He then joined the Tulane University Obesity Research Center as a postdoctoral fellow under the supervision of Dr.Lu Qi.Dr.Sun's current research interests include chronic disease epidemiology,multi-omics of obesity,diabetes,cardiovascular diseases,as well as ageing and life-course epidemiology.
E-mail:dsun1@bjmu.edu.cn
李立明 北京大学公共卫生学院教授、博士生导师。亚太公共卫生科学理事会选举委员会主任委员、世界卫生组织行为干预专家委员会委员、国务院学科评议组公共卫生与预防医学组负责人,以及《中华流行病学杂志》和《中国公共卫生管理杂志》主编、《中国预防医学杂志》和《中国慢性病预防与控制》副主编。历任北京大学校长助理、北京大学医学部副主任、中国预防医学科学院院长、中国疾病控制中心首任主任、中国医学科学院/北京协和医学院党委书记、常务副院长。主要研究方向为慢性病流行病学、老年保健流行病学、医学教育与公共卫生学教育、卫生政策与卫生事业管理,以及系统流行病学。
E-mail:lmlee@bjmu.edu.cn
LI Liming The Boya Chair Professor in the Department of Epidemiology&Biostatistics,School of Public Health,Peking University Health Science Center.He worked successively as Assistant to the President of Peking University,President of Chinese Academy of Preventive Medicine (CAPM),the first Director-General of Chinese Center for Disease Control and Prevention (CDC),Board Chair and Executive Vice President of Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC).His academic research has focused on chronic disease epidemiology,the prevention and control of non-communicable diseases,geriatric epidemiology,medical and public health education&management,evidence-based decision making,and systems epidemiology.
E-mail:lmlee@bjmu.edu.cn
E-mail:dsun1@bjmu.edu.cn
SUN Dianjianyi Assistant Professor in the Department of Epidemiology&Biostatistics,School of Public Health,Peking University Health Science Center.His interest in epidemiology of cardiometabolic diseases led him to pursue a Ph.D.degree in Epidemiology and Biostatistics at Peking University.He completed his Ph.D.research investigating the role of DNA methylation in the development of cardiometabolic disorders from 2010 to 2015.He then joined the Tulane University Obesity Research Center as a postdoctoral fellow under the supervision of Dr.Lu Qi.Dr.Sun's current research interests include chronic disease epidemiology,multi-omics of obesity,diabetes,cardiovascular diseases,as well as ageing and life-course epidemiology.
E-mail:dsun1@bjmu.edu.cn
李立明 北京大学公共卫生学院教授、博士生导师。亚太公共卫生科学理事会选举委员会主任委员、世界卫生组织行为干预专家委员会委员、国务院学科评议组公共卫生与预防医学组负责人,以及《中华流行病学杂志》和《中国公共卫生管理杂志》主编、《中国预防医学杂志》和《中国慢性病预防与控制》副主编。历任北京大学校长助理、北京大学医学部副主任、中国预防医学科学院院长、中国疾病控制中心首任主任、中国医学科学院/北京协和医学院党委书记、常务副院长。主要研究方向为慢性病流行病学、老年保健流行病学、医学教育与公共卫生学教育、卫生政策与卫生事业管理,以及系统流行病学。
E-mail:lmlee@bjmu.edu.cn
LI Liming The Boya Chair Professor in the Department of Epidemiology&Biostatistics,School of Public Health,Peking University Health Science Center.He worked successively as Assistant to the President of Peking University,President of Chinese Academy of Preventive Medicine (CAPM),the first Director-General of Chinese Center for Disease Control and Prevention (CDC),Board Chair and Executive Vice President of Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC).His academic research has focused on chronic disease epidemiology,the prevention and control of non-communicable diseases,geriatric epidemiology,medical and public health education&management,evidence-based decision making,and systems epidemiology.
E-mail:lmlee@bjmu.edu.cn
